Dose-ranging studies
Related Experiment Video
Updated: Oct 18, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
1Worldwide Medical Affairs, DuPont Pharmaceuticals Company, Wilmington, USA.
Abstract:
Several studies have been performed to investigate the appropriate dose of efavirenz (SUSTIVA, DMP 266, EFV) for the treatment of HIV infection. When considering the most appropriate dose, virological, pharmacological, clinical and safety data from these studies were examined. Efavirenz 600 mg once daily is the recommended dose of efavirenz for combination therapy in adults. Efavirenz 600 mg once daily adjusted for body size is the appropriate dose for combination therapy in children three years of age or older.
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dose Response Curve: Conventional Versus Nonmonotonic
Dosage Regimens: Designs and Approaches
Dosage Regimen: Multiple Oral Dosage

